Barry A. Polisky
Chief Executive Officer at Microbial Machines, Inc.
Active connections
Name | Gender | Age | Linked companies | Collaboration |
---|---|---|---|---|
Julia Novina | F | - |
Microbial Machines, Inc.
SanaRx Biotherapeutics, Inc.
SanaRx Biotherapeutics, Inc. Pharmaceuticals: MajorHealth Technology SanaRx Biotherapeutics, Inc. is a biotechnology company. It serves patients with orphan diseases of the alimentary tract. The company is headquartered in Medford, MA.
NextRNA Therapeutics, Inc.
NextRNA Therapeutics, Inc. BiotechnologyHealth Technology NextRNA Therapeutics, Inc. is a biotechnology company that specializes in drug development services. The company is based in Cambridge, MA. The company was founded in 2021 by Leon Wert-Lamas, Marc A. Cohen, Julia Novina, Carl Novina, Dominique Verhelle, Kenneth C. Anderson, Robert S. Langer. Dominique Verhelle has been the CEO since 2021. | 5 years |
Dominique Verhelle | M | - |
NextRNA Therapeutics, Inc.
NextRNA Therapeutics, Inc. BiotechnologyHealth Technology NextRNA Therapeutics, Inc. is a biotechnology company that specializes in drug development services. The company is based in Cambridge, MA. The company was founded in 2021 by Leon Wert-Lamas, Marc A. Cohen, Julia Novina, Carl Novina, Dominique Verhelle, Kenneth C. Anderson, Robert S. Langer. Dominique Verhelle has been the CEO since 2021. | 3 years |
Carl Novina | M | - |
SanaRx Biotherapeutics, Inc.
SanaRx Biotherapeutics, Inc. Pharmaceuticals: MajorHealth Technology SanaRx Biotherapeutics, Inc. is a biotechnology company. It serves patients with orphan diseases of the alimentary tract. The company is headquartered in Medford, MA.
NextRNA Therapeutics, Inc.
NextRNA Therapeutics, Inc. BiotechnologyHealth Technology NextRNA Therapeutics, Inc. is a biotechnology company that specializes in drug development services. The company is based in Cambridge, MA. The company was founded in 2021 by Leon Wert-Lamas, Marc A. Cohen, Julia Novina, Carl Novina, Dominique Verhelle, Kenneth C. Anderson, Robert S. Langer. Dominique Verhelle has been the CEO since 2021. | 3 years |
Kendra Abercombie | F | - |
Indiana University
| - |
Jon Trinidad | M | - |
Indiana University
| - |
Tony Armstrong | M | - |
Indiana University
| - |
Andrew Lauck | M | 38 |
Indiana University
| - |
Jeffrey Wagner | M | - |
Microbial Machines, Inc.
| 5 years |
Fred H. Mermelstein | M | 64 |
SanaRx Biotherapeutics, Inc.
SanaRx Biotherapeutics, Inc. Pharmaceuticals: MajorHealth Technology SanaRx Biotherapeutics, Inc. is a biotechnology company. It serves patients with orphan diseases of the alimentary tract. The company is headquartered in Medford, MA.
NextRNA Therapeutics, Inc.
NextRNA Therapeutics, Inc. BiotechnologyHealth Technology NextRNA Therapeutics, Inc. is a biotechnology company that specializes in drug development services. The company is based in Cambridge, MA. The company was founded in 2021 by Leon Wert-Lamas, Marc A. Cohen, Julia Novina, Carl Novina, Dominique Verhelle, Kenneth C. Anderson, Robert S. Langer. Dominique Verhelle has been the CEO since 2021. | - |
Bobby Sandage | M | 70 |
Microbial Machines, Inc.
NextRNA Therapeutics, Inc.
NextRNA Therapeutics, Inc. BiotechnologyHealth Technology NextRNA Therapeutics, Inc. is a biotechnology company that specializes in drug development services. The company is based in Cambridge, MA. The company was founded in 2021 by Leon Wert-Lamas, Marc A. Cohen, Julia Novina, Carl Novina, Dominique Verhelle, Kenneth C. Anderson, Robert S. Langer. Dominique Verhelle has been the CEO since 2021. | 2 years |
Tom Glocer | M | 63 | 17 years | |
Drew Dennison | M | - |
SanaRx Biotherapeutics, Inc.
SanaRx Biotherapeutics, Inc. Pharmaceuticals: MajorHealth Technology SanaRx Biotherapeutics, Inc. is a biotechnology company. It serves patients with orphan diseases of the alimentary tract. The company is headquartered in Medford, MA. | - |
Kenneth Anderson | M | 72 |
NextRNA Therapeutics, Inc.
NextRNA Therapeutics, Inc. BiotechnologyHealth Technology NextRNA Therapeutics, Inc. is a biotechnology company that specializes in drug development services. The company is based in Cambridge, MA. The company was founded in 2021 by Leon Wert-Lamas, Marc A. Cohen, Julia Novina, Carl Novina, Dominique Verhelle, Kenneth C. Anderson, Robert S. Langer. Dominique Verhelle has been the CEO since 2021. | 3 years |
Kenneth Gyan | M | - |
Indiana University
| - |
Susan Siena | F | - |
Indiana University
| - |
Amy Pickard | F | - |
Indiana University
| - |
Jonathan Schlebach | M | - |
Indiana University
| - |
Alex Stralker | M | - |
Indiana University
| - |
Matt Hottell | M | - |
Indiana University
| - |
Ethan Fairbanks | M | - |
Indiana University
| - |
Bruce Sales | M | - |
Indiana University
| - |
Evelyn Gil | F | - |
Indiana University
| - |
Danielle DeSawal | F | - |
Indiana University
| - |
Kimberly Mattioli | F | - |
Indiana University
| - |
Jose Antinao-Rojas | M | - |
Indiana University
| - |
Katie Metz | F | - |
Indiana University
| - |
Mark McConahay | M | - |
Indiana University
| - |
Alexandre Lopes | M | - |
Indiana University
| - |
Alex Alexeev | M | - |
Indiana University
| - |
Stephen Wyrczynki | M | - |
Indiana University
| - |
Elizabeth Hebbard | F | - |
Indiana University
| - |
Clark Barwick | M | - |
Indiana University
| - |
John Arthos | M | - |
Indiana University
| - |
Caleb Weintraub | M | - |
Indiana University
| - |
Joanna Woronkowicz | F | - |
Indiana University
| - |
Betsy Stirratt | F | - |
Indiana University
| - |
Sean Starowitz | M | - |
Indiana University
| - |
Paul Gutjahr | M | - |
Indiana University
| - |
Justin Garcia | M | - |
Indiana University
| - |
Rebecca Fasman | F | - |
Indiana University
| - |
Robert Billingham | M | - |
Indiana University
| - |
Norman Hedges | M | - |
Indiana University
| - |
Rachel Ryder | F | - |
Indiana University
| - |
Leah Savion | F | - |
Indiana University
| - |
Jason Jedlicka | M | - |
Indiana University
| - |
Danielle DeSawall | F | - |
Indiana University
| - |
Carrie Docherty | F | - |
Indiana University
| - |
Dan Calarco | M | - |
Indiana University
| - |
Adam Ratzman | M | - |
Indiana University
| - |
Jeff Perotti | M | - |
Indiana University
| - |
Anne Leftwich | F | - |
Indiana University
| - |
Anne Delgado | F | - |
Indiana University
| - |
Ronald Whitaker | M | 76 |
Indiana University
| 7 years |
Peter Kolbaum | M | - |
Indiana University
| - |
William H. Beeson | M | - |
Indiana University
| - |
David A. Ingram | M | - |
Indiana University
| - |
Mervin C. Yoder | M | - |
Indiana University
| - |
Chuck Franz | M | - |
Indiana University
| - |
Gerald J. Longa | M | - |
Indiana University
| - |
Jerome H. Fleisch | M | - |
Indiana University
| - |
J. Enright | M | 61 |
Indiana University
| - |
Sandy DeWeese | F | - |
Indiana University
| - |
Nick James | M | - |
Indiana University
| - |
Bill West | M | 57 |
Indiana University
| - |
Daniel F. Evans | M | 74 |
Indiana University
| - |
Kathryn Ernstberger | F | 61 |
Indiana University
| - |
David Shane | M | 76 |
Indiana University
| - |
Susanne S. Ridlen | M | - |
Indiana University
| - |
Richard DiMarchi | M | 71 |
Indiana University
| 21 years |
Stephen Sterrett | M | 68 |
Indiana University
| - |
David W. Crabb | M | 70 |
Indiana University
| 41 years |
David L. Beré | M | 70 |
Indiana University
| - |
Sarah L. Hanssen | F | - |
Indiana University
| - |
Linda H. Malkas | M | - |
Indiana University
| - |
Brent Gault | M | - |
Indiana University
| - |
Justin Harrison | M | - |
Indiana University
| - |
Benjamin Chupps | M | - |
Indiana University
| - |
Margaret Kiel-Morse | F | - |
Indiana University
| - |
Natalie Techentin | F | - |
Indiana University
| - |
Julia Newnum | F | - |
Indiana University
| - |
Marie Johns | F | 72 |
Indiana University
| - |
Neil Powell | M | - |
Indiana University
| 5 years |
Michael Coyle | M | - |
Indiana University
| - |
Mary Anna Weber | F | - |
Indiana University
| - |
Robert J. Hickey | M | - |
Indiana University
| - |
Eric M. Meslin | M | - |
Indiana University
| 23 years |
Doug Rex | M | - |
Indiana University
| - |
Michael J. Detke | M | 57 |
Indiana University
| - |
James Glazier | M | - |
Indiana University
| - |
Jeffey Wilson | M | - |
Indiana University
| - |
Jean Bandos | F | - |
Indiana University
| - |
Dale Dellacqua | M | - |
Indiana University
| - |
Derek J. Hoelz | M | - |
Indiana University
| - |
Diana Dingman | F | - |
Indiana University
| - |
Connections Chart
Multi-company connection
Former connections
Name | Gender | Age | Linked companies | Collaboration |
---|---|---|---|---|
Peter García | M | 62 |
MDRNA, Inc.
MDRNA, Inc. Miscellaneous Commercial ServicesCommercial Services MDRNA, Inc. engages in development and commercialization of innovative products based on proprietary molecular biology-based intranasal drug delivery technology. The company creates or utilizes novel formulation components or excipients that can transiently manipulate or open 'tight junctions' between cells in various tissues and thereby allow therapeutic drugs to reach the blood stream. The company is located in Hauppauge, NY. | 2 years |
Philip C. Ranker | M | 64 | 7 years | |
Howard Robin | M | 71 |
Sirna Therapeutics, Inc.
Sirna Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Sirna Therapeutics, Inc. creates potent and stable siRNA compounds that are delivered into human cells resulting in the silencing of genes and viruses responsible for human diseases. The firm creates RNAi- based therapies to treat patients. The company was founded in 1992 and is headquartered in San Francisco, CA. | 5 years |
James Karis | M | 76 |
MDRNA, Inc.
MDRNA, Inc. Miscellaneous Commercial ServicesCommercial Services MDRNA, Inc. engages in development and commercialization of innovative products based on proprietary molecular biology-based intranasal drug delivery technology. The company creates or utilizes novel formulation components or excipients that can transiently manipulate or open 'tight junctions' between cells in various tissues and thereby allow therapeutic drugs to reach the blood stream. The company is located in Hauppauge, NY. | 3 years |
Bruce R. York | M | 69 |
MDRNA, Inc.
MDRNA, Inc. Miscellaneous Commercial ServicesCommercial Services MDRNA, Inc. engages in development and commercialization of innovative products based on proprietary molecular biology-based intranasal drug delivery technology. The company creates or utilizes novel formulation components or excipients that can transiently manipulate or open 'tight junctions' between cells in various tissues and thereby allow therapeutic drugs to reach the blood stream. The company is located in Hauppauge, NY. | 6 years |
Michael Taylor | M | 69 | 2 years |
Statistics
Country | Connections | % of total |
---|---|---|
United States | 100 | 100.00% |
Age of Connections
Active
Past
Male
Female
Members of the board
Executives
Origin of connections
- Stock Market
- Insiders
- Barry A. Polisky
- Personal Network